Hint mode is switched on Switch off
For swift navigation between sections

Fagron

Organization name
Fagron NV
Country name
Belgium
Country of registration
Belgium
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds
  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Fagron NV, formerly Arseus NV, is a Belgium-based company that provides products and services for professionals and institutions active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier. The Company is active in two divisions: Fagron, which supplies pharmaceutical raw materials, equipment and supplies, concepts, and pharmaceutical compounding to pharmacies and hospital pharmacies in over 30 countries; and HL Technology, which develops and produces precision components and orthopedic tools for dental and medical professionals. The Company is active in around 30 countries in Europe, the Americas, the Middle East, Africa, Asia and the Pacific.

Awards

Documentation

Stocks

Latest issues

Public debt by currencies

Codes

  • SIC
    5122 WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Registration is required to get access.